Auszug
Herzinsuffizienz bezeichnet ein komplexes klinisches Syndrom, das durch Störungen der linksventrikulären Funktion und der neuroendokrinen Regulation gekennzeichnet ist und von Symptomen wie verminderte Belastbarkeit, Flüssigkeitsretention und eingeschränkter Lebenserwartung begleitet wird. Pathophysiologisch kann Herzinsuffizienz als Zustand gestörter Herzfunktion aufgefasst werden, der dazu führt, dass das Herz nicht in der Lage ist, ein für den Bedarf des Organismus ausreichendes Herzminutenvolumen zu fördern und/oder dies nur unter abnormal erhöhten Füllungsdrücken leisten kann.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American College of Cardiology/American Heart Association taskforce on practice guidelines (2001) ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. JACC 38:2101–2113
CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 316:1429–1435
Digitalis Investigative Group (1997) The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336:525–33
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384–416
Kass DA, Chen CH, Curry C, Talbot M, Berger R, Fetics B, Nevo E (1999) Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 99:1567–1573
Leitlinien zur Therapie der Herzinsuffizienz der Deutschen Gesellschaft für Kardiologie (2005) Z Kardiol 94:488–509
MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001–2007
Packer M, Bristow MR, Cohn JN, Colucci WS et al. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349–1355
Packer M, Coats AJ, Fowler MB et al. (Carvedilol Prospective Randomized Cumulative Survival Study Group) (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658
Pitt B, Zannad F, Remme WJ et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717
Remme WJ, Swedberg K (Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology) (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22:1527–1560
SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 327: 685–691
Yusuf S, Pfeffer MA, Swedberg K et al. (2003) Effects of candesartan in patients with chronic heart failure and preserved leftventricular ejection fraction: the CHARM-Preserved trial. Lancet 362:777–781
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Hermann, HP., Hasenfuß, G. (2007). Herzinsuffizienz. In: Schölmerich, J. (eds) Medizinische Therapie 2007 | 2008. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48554-4_121
Download citation
DOI: https://doi.org/10.1007/978-3-540-48554-4_121
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-48553-7
Online ISBN: 978-3-540-48554-4
eBook Packages: Medicine (German Language)